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Abstract The requirement for novel decontamination
technologies for use in hospitals is ever present. One such
system uses 405 nm visible light to inactivate microorgan-
isms via ROS-generated oxidative damage. Although
effective for bacterial and fungal inactivation, little is known
about the virucidal effects of 405 nm light. Norovirus (NoV)
gastroenteritis outbreaks often occur in the clinical setting,
and this study was designed to investigate potential inacti-
vation effects of 405 nm light on the NoV surrogate, feline
calicivirus (FCV). FCV was exposed to 405 nm light whilst
suspended in minimal and organically-rich media to estab-
lish the virucidal efficacy and the effect biologically-relevant
material may play in viral susceptibility. Antiviral activity
was successfully demonstrated with a 4 Log10 (99.99%)
reduction in infectivity when suspended in minimal media
evident after a dose of 2.8 kJ cm-2. FCV exposed in arti-
ficial faeces, artificial saliva, blood plasma and other
organically rich media exhibited an equivalent level of
inactivation using between 50–85% less dose of the light,
indicating enhanced inactivation when the virus is present in
organically-rich biologically-relevant media. Further
research in this area could aid in the development of 405 nm
light technology for effective NoV decontamination within
the hospital environment.
Keywords 405 nm Light  Viral inactivation  Feline
calicivirus  Saliva  Faeces  Plasma
Introduction
Norovirus (NoV), one of the most common causes of epi-
demic acute gastroenteritis (Hall et al. 2013), can be trans-
mitted via food and water, person-to-person contact or
contact with environmental surfaces (Robilotti et al. 2015).
Environmental stability and resistance to disinfection further
aid the transmission of NoV, with viral particles detected on
surfaces up to 42 days after contamination (Escudero et al.
2012). If environmental decontamination is deficient, this
can lead to ward closures which has substantial operational
and financial implications for health boards (Wu et al. 2005;
Danial et al. 2011). NoV outbreaks in the healthcare setting
and other densely populated areas such as nursing homes,
schools and restaurants (Robilotti et al. 2015) have driven
the need for new decontamination systems.
Advanced decontamination technologies used to over-
come nosocomial outbreaks include ozone, hydrogen per-
oxide vapour and UV-light systems (Maclean et al. 2015).
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These technologies are time consuming with hospital wards
required to be vacated to prevent harmful effects to patients
and staff (Otter et al. 2013), and are therefore suited to
terminal cleaning. A technology using 405 nm violet-blue
visible light has been developed to provide continuous
decontamination of occupied hospital environments (Ma-
clean et al. 2014). Application of 405 nm light for decon-
tamination in hospitals has been demonstrated, with levels of
bacterial contamination on environmental surfaces around
occupied isolation rooms reduced by up to 86% over and
above reductions achieved by traditional cleaning alone
(Maclean et al. 2010, 2013a; Bache et al. 2012).
It has been demonstrated that 405 nm violet-blue light has
germicidal activity against a range of bacteria and fungi
(Guffey and Wilborn 2006; Enwemeka et al. 2008; Maclean
et al. 2009, 2013b; Murdoch et al. 2013), effected through
excitation of endogenous photosensitive porphyrin molecules
within microbial cells, causing the production of singlet oxy-
gen and other reactive oxygen species (ROS), resulting in
oxidative damage and microbial cell death (Hamblin and
Hasan 2004; Maclean et al. 2008; Murdoch et al. 2013). A
study investigating the efficacy of 405 nm light on the bacte-
riophage/C31 indicated that the phagewas susceptible to high
doses of 405 nm light, with susceptibility significantly
enhanced when exposed in nutrient-rich media (Tomb et al.
2014). However, as virions do not contain endogenous por-
phyrins (Gelderblom 1996), current knowledge on the antiviral
efficacy of 405 nm light on medically important human and
animal viruses is lacking and requires investigation.
This study was designed to provide the first proof-of-
concept of the interaction of narrowband 405 nm light with
feline calicivirus (FCV) as a model to study the antiviral
effects of this light on NoV. Feline calicivirus was selected
as a NoV surrogate, as there is currently no standardised
cell culture system for NoV (Duizer et al. 2004a; Richards
2012; Cromeans et al. 2014). Our data demonstrate the
influence of the suspending media, including biologically-
relevant fluids, on viral susceptibility. As such, this study
provides evidence of the antiviral efficacy and discusses
the potential mechanism of 405 nm light viral inactivation.
Methodology
Cell and Virus Culture
Feline embryonic cells, strain FEA (Jarrett et al. 1973),
were cultured in Dulbecco’s modified eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum
(FBS), 2 mM L-glutamine, 1 mM sodium pyruvate and 240
U mL-1 penicillin streptomycin (Gibco, Life Technolo-
gies, UK), to form 10% FBS-DMEM. Cells were main-
tained at 37 C in 5% CO2.
To prepare a virus pool of the FCV vaccine strain F9,
virus inoculum (School of Veterinary Medicine, University
of Glasgow) was added to FEA monolayers in 850 cm2 cell
culture roller flasks (Corning, USA). After 90 min incu-
bation of the inoculated cells on a rotating roller stand at
37 C in 5% CO2, fresh culture medium was added and
flasks incubated for 24 h. This resulted in virus-induced
destruction of nearly 90% of the cell monolayer.
The tissue culture supernatant, and medium from a
single wash step, was collected from each roller bottle and
subjected to two freeze–thaw cycles before clarification by
centrifugation at 33009g for 10 min. The virus-containing
supernatant was then stored at -80 C until required. The
infectious titre of FCV was approximately 2 9 107 plaque-
forming units per millilitre (PFU mL-1), determined by
standard plaque assay techniques (Ormerod and Jarret
1978).
405 nm Light Source
The light source used was a 405 nm light emitting diode
(LED) array (ENFIS PhotonStar Innovate UNO 24; Pho-
tonStar Technologies, UK) powered by a 40 V Phillips
Xitanium LED Driver (Phillips, Netherlands). The array
had a peak wavelength around 405 nm and a bandwidth of
approximately 19 nm (Fig. 1) but will, for convenience, be
referred throughout this text as 405 nm light. The array was
attached to a heatsink and cooling fan, to minimise heat
transfer to test samples, so that no significant heating of the
sample occurred. The light source was held on a PVC stand
at a distance of 4 cm from the microbial samples, giving an
irradiance of 155.8 mW cm-2 at the sample surface
[measured using a radiant power meter and photodiode
detector (LOT Oriel, USA)].
Fig. 1 Optical emission spectrum of the 405 nm LED array,
measured using an HR4000 spectrometer (Ocean Optics, Germany)
and Spectra Suite software version 2.0.151
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405 nm Light Exposure of Viral Suspensions
Feline calicivirus stock virus was defrosted at room tem-
perature and diluted to 2 9 105 PFU mL-1 in Dulbecco’s
phosphate-buffered saline, supplemented with calcium and
magnesium (DPBS; Hyclone, Thermo Fischer Scientific,
UK). This was used as a ‘minimal medium’ (MM). Viral
suspension of 1.5 mL were transferred into the central four
wells of a 24-well plate (Techno Plastic Products,
Switzerland) and the plate positioned on a raised stand,
with the sample wells at 4 cm directly below the light
source and the plate lid kept on to prevent evaporation.
Test samples were exposed to increasing doses of 405 nm
light at room temperature, with the dose calculated as the
product of irradiance (mW cm-2) 9 exposure time (s).
Control samples were set up under identical environmental
conditions but without 405 nm light illumination. Post-
exposure, FCV samples were serially diluted in MM for
enumeration by plaque assay.
Exposures were repeated with FCV suspended in
‘organically-rich media’ (ORM): DMEM, 10% FBS-
DMEM, artificial saliva, artificial faeces and blood plasma.
The artificial saliva was a modified version of that used by
Margomenou et al. (2000) [5.2 g NaHCO3, 0.88 g NaCl,
1.36 g K2HPO4, 0.48 g KCl, 2000 units a-amylase and 2 g
pig gastric mucin (Sigma-Aldrich, UK) in 1 L sterile water],
and was adjusted to pH of 7–7.5 to emulate the variability of
pH in human saliva, and also to ensure that no FCV inacti-
vation occurred (Duizer et al. 2004b; Edgar et al. 2004). The
artificial faeces was amodified version of that by Colo´n et al.
(2015) [30 g inactivated yeast (Marigold, UK), 7 g physil-
lum (Buy Whole Foods Online, UK), 11 g miso paste (Yu-
taka, UK), 8 g cellulose, 1.6 g NaCl, 0.8 g CaCl, 1.6 g KCl
(Sigma-Aldrich) in 920 mL sterile water], and was also
adjusted to pH 7. The modifications to the formulations of
artificial saliva and faeces were to ensure compatibility with
the FEA cells. Fresh frozen human blood plasma was
obtained from the Scottish National Blood Transfusion
Service (SNBTS, UK), and defrosted before use. FCV was
also exposed when suspended in MM supplemented with
riboflavin, with and without tyrosine, tryptophan, pyridox-
ine and folic acid (used at the same concentrations as found
in DMEM: 0.4, 104, 16, 4 and 4 mg L-1 respectively).
Plaque Assay
Prior to experiments, 6-well cell culture plates (Thermo
Fischer Scientific) were seeded with 7.5 9 105 FEA cells
per well. 3 mL of the cell suspension in growth medium
was pipetted into each well, and incubated at 37 C in 5%
CO2 for 20 h, resulting in confluent monolayers.
Post-exposure of FCV, the growth medium was aspi-
rated from the FEA cells and replaced with 1 mL FCV
sample. Plates were co-incubated at 37 C in a humidified
5% CO2 incubator for 90 min, with the plates gently
rocked every 15 min to ensure even distribution of the
inoculum over each monolayer.
After the viral incubation period, the inoculum was aspi-
rated and thewell washedwithmedium (10%FBS-DMEMor
DPBS) before adding 4 mL overlay mixture consisting of
29 supplemented DMEM 1:1 with 29 agarose. 29 supple-
mented DMEM was prepared using 20 mL from a filter-
sterilised stock of 109 DMEM, adding the same supplements
as detailed earlier, plus 9.86 mL sodium bicarbonate solution
(Gibco), and was made up to 100 mL with sterile water.
29 agarose was prepared by dissolving 2 g agarose (Sigma-
Aldrich) in 100 mL deionised distilled water and then ster-
ilised by autoclaving. The overlay was left to set before the
plates were incubated for 44–48 h at 37 C in 5% CO2.
Post-incubation, the monolayers were fixed and stained
overnight with 0.5% crystal violet in 10% neutral buffered
formalin. The agarose plugs and stain were then removed,
the plates left to dry, plaques counted, and the virus
infectivity titre expressed as PFU mL-1.
Spectrophotometry
The transmission of 405 nm light through the suspending
media was measured using a Biomate 5-UV–Visible spec-
trophotometer (Thermo Fischer Scientific). The presence of
porphyrins, or other components with the ability to absorb
405 nm light and emit fluorescence, within the suspending
media was determined by fluorescence spectrophotometry.
Media were freshly prepared, and fluorescence measurements
were carried out using a RF-5301 PC spectrofluorophotometer
(Shimadzu, USA). Excitation was carried out at 405 nm and
emission spectra recorded between 425 and 700 nm.
Data Analysis
Data points represent mean results ± standard deviation
(SD), taken from triplicate independent experiments
(n = C3). The antiviral activity of 405 nm light was
determined by calculating the reduction in the level of
infectivity from the difference between Log10 values for
exposed and control samples. Significant differences were
calculated at a 95% significance level, using paired t-tests
or one-way ANOVA (Minitab 16 Statistical Software),
with results found to be significant when P\ 0.05.
Results
Feline calicivirus was suspended in MM and ORM and
exposed to increasing doses of 405 nm light at an irradi-
ance of 155.8 mW cm-2. Results (Fig. 2) show that when
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suspended in MM, significant FCV inactivation was
achieved after exposure to 561 J cm-2 (P = 0.043), and
relatively linear inactivation kinetics were observed, with a
dose of 2.8 kJ cm-2 required for a 3.9 Log10 inactivation.
The non-exposed control samples showed no significant
change over the course of the experiment (P[ 0.05).
Antiviral efficacy was found to differ significantly when
suspended in ORM. When exposed in 10% FBS-DMEM, a
significantly lower dose was required for viral inactivation
(Fig. 3), with a 4.8 Log10 reduction achieved after a dose of
421 J cm-2. As the presence of FBS in DMEM is thought
to reduce the level of oxidation upon exposure to normal
laboratory lighting (Grzelak et al. 2001), the exposure was
repeated with FCV suspended in DMEM without FBS to
observe any differences in inactivation kinetics. Although
slightly greater inactivation was observed with each
applied dose, results (Fig. 3) demonstrate no significant
differences in the inactivation kinetics of FCV when the
virus is exposed in DMEM in the presence or the absence
of 10% FBS (P[ 0.05). Control samples showed no sig-
nificant decrease (P[ 0.05).
Furthermore, components of DMEM have been shown
to be photosensitive to light (Grzelak et al. 2001), and
therefore, exposures were repeated with riboflavin added to
MM with and without tyrosine, tryptophan, pyridoxine and
folic acid in the same concentrations as found in DMEM
(Table 1). Results demonstrated that exposure of FCV
suspended in MM with riboflavin only resulted in a 1.3
Log10 reduction after 421 J cm
-1; however, when all
components were present, enhanced inactivation occurred
and a 5.1 Log10 inactivation was achieved.
Artificial saliva, artificial faeces and blood plasma were
selected as ORM which are biologically relevant in terms
of media in which viral particles may be found in the
environment, with NoV being regularly identified in fae-
ces. Exposure of FCV when suspended in artificial saliva
yielded results similar to those in DMEM, with a 5.1 Log10
reduction of infectivity achieved after a dose of
Fig. 2 Inactivation of feline calicivirus when suspended in minimal
medium (Dulbecco’s phosphate buffered saline), upon exposure to
405 nm light at an irradiance of 155.8 mW cm-2. Data points show
the mean counts (n = 6) ± SD. Asterisks indicate light-exposed
samples that were significantly different to the non-exposed final
control samples (P B 0.05), using one-way ANOVA. No significant
decrease was observed in the final control populations (P C 0.05)
Fig. 3 Comparison of the
inactivations of feline
calicivirus when suspended in
organically-rich media
[supplemented Dulbecco’s
modified eagle’s medium,
without and without 10% fetal
bovine serum (FBS)], upon
exposure to 405 nm light at an
irradiance of 155.8 mW cm-2.
Data points show the mean
counts (n = 3) ± SD.
Statistical analysis, using a
paired t test, showed no
significant difference between
inactivations in the two media
(P[ 0.05). No significant
decrease was observed in the
final control populations
(P C 0.05)
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421 J cm-2 (Fig. 4a). (In this case, inactivation was mea-
sured to a sensitivity of ten PFU mL-1, as the artificial
saliva in the undiluted samples adversely reacted with the
FEA cells causing them to dislodge from the plate). The
dose required for inactivation when suspended in blood
plasma was slightly greater than that required when in
artificial saliva, with 561 J cm-2 being required for 4.8
log10 inactivation of FCV (Fig. 4a). FCV inactivation in
artificial faeces required greater doses, with 4.5 log10
inactivation achieved after 1.4 kJ cm-2 (Fig. 4b). Control
samples in artificial saliva, plasma and artificial faeces
showed no significant changes (P = 0.618, 0.101, 0.747,
respectively).
Optical analysis of the suspending media demonstrated
the transmission of 405 nm light to be 90% in DPBS,
40.6% in DMEM, 30.6% in 10% FBS-DMEM, 35.9% in
artificial saliva, 0.05% in artificial faeces, and 2.1% in
blood plasma (n = 4). The fluorescence emission spectra
(Fig. 5) of MM (DPBS) and ORM (DMEM, 10% FBS-
DMEM, artificial saliva, artificial faeces and blood plasma)
when excited at 405 nm, show emission peaks for DMEM,
10% FBS-DMEM, artificial faeces and blood plasma
observed between 510 and 520 nm and for artificial saliva
at 460 nm.
Discussion
Although there has been a recent move towards using
Murine Norovirus and Tulane Virus, alongside FCV, as
NoV surrogates (Cromeans et al. 2014; Kniel 2014; Chui
et al. 2015; Esseili et al. 2015; Zonta et al. 2016), FCV was
chosen as it has physiochemical and genomic similarities to
NoV, and is a well-established surrogate with a standard-
ised cell culture protocol (Doultree et al. 1999; Bidawid
et al. 2003; Duizer et al. 2004a, 2004b; Chander et al.
2012). Similarly, studies investigating the virucidal effects
of UV-light, ozone, hydrogen peroxide vapour and cold
atmospheric gas plasma technologies have also used FCV
as a NoV surrogate (Nuswalen et al. 2002; Hudson et al.
2007; Bentley et al. 2012; Aboubaktar et al. 2015; Holm-
dahl et al. 2016).
The virucidal efficacy of 405 nm light was determined
using FCV suspended in both MM and ORM. Exposure in
MM would provide a better indication of the interaction of
405 nm light and the virus alone, when under suspension in
ORM, which is likely to contain photosensitive compo-
nents, and would assess how viral susceptibility can
potentially be influenced by the surrounding media.
Successful FCV inactivation was achieved when sus-
pended in MM, although the dose required was substan-
tially great, with 2.8 kJ cm-2 achieving a 3.9 Log10
reduction (Fig. 2). In the case of bacteria and fungi in MM,
doses in the range of 18–576 J cm-2 are typically required
for 5 Log10 inactivations (Maclean et al. 2009; Murdoch
et al. 2012, 2013). The increased susceptibility of bacteria
and fungi compared with viruses is accredited to the
presence of endogenous photosensitive porphyrins within
these cells (Hamblin and Hasan 2004; Maclean et al. 2008;
Murdoch et al. 2013). Low sensitivity of FCV in MM was
anticipated due to the absence of porphyrins in the viral
structure, coupled with the fact that MM does not contain
any photosensitive substances which absorb light at
405 nm (Fig. 5), suggesting that viral inactivation, in this
case, is due to a differing mechanism.
An alternative mechanism of inactivation when FCV is
suspended in MM may be associated with the LED emis-
sion spectrum extending slightly into the UVA region
(Fig. 1), meaning the virus is exposed to very low-level
UVA photons (*390 nm). Over an extended period, this
could cause oxidative damage to proteins (Girard et al.
2011), for example, to the viral capsid, and therefore
contribute to the observed inactivation. Another possibility
is that the small amount of 420–430 nm light emitted from
the source may contribute to viral inactivation. Antiviral
effects of 420–430 nm have been demonstrated against
murine leukaemia virus, with long exposures thought to
cause photo-damage to the virion-associated reverse
Table 1 Comparison of the inactivations of feline calicivirus when suspended in minimal media supplemented with riboflavin alone or
alongside tyrosine, tryptophan, pyridoxine and folic acid, upon exposure to 405 nm light at an irradiance of 155.8 mW cm-2
Photosensitive
components
Starting population, Log10
PFU mL-1 (± SD)
Exposed viral population,
Log10 PFU mL
-1 (± SD)
Non-exposed control population,
Log10 PFU mL
-1 (± SD)
Log10 reduction,
PFU mL-1 (P value)
Riboflavin 5.01 ± 0.02 3.77 ± 0.61 5.05 ± 0.06 1.28* (P = 0.00)
Riboflavin
Tyrosine
Tryptophan
Pyridoxine
Folic acid
5.15 ± 0.03 0.00 ± 0.00 5.12 ± 0.07 5.12* (P = 0.00)
Data points represent the mean count (n = 3) ± SD
* Light-exposed samples that were significantly different to the non-exposed final control samples (P B 0.05)
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transcription complex (Richardson and Porter 2005).
Although the virus differs in structure to FCV, these find-
ings suggest that the prolonged exposure to wavelengths at
the tail ends of the 405 nm LED emission spectrum such as
390 and 420 nm, as well as 405 nm, may affect the viruses’
ability to infect and replicate in host cells, and have a role
in the inactivation of FCV by the LEDs used in this study.
To investigate whether exposure in ORM had any effect
on viral susceptibility, FCV was first suspended in DMEM
with and without 10% FBS, thought to aid protection
against ROS (Grzelak et al. 2001). Results (Fig. 3)
demonstrated near complete reduction in infectivity of a
105 PFU mL-1 population after a dose of 421 J cm-2. As
can be seen in Fig. 3, slightly greater inactivation occurred
Fig. 4 Inactivation of feline
calicivirus suspended in
a artificial saliva or plasma and
b artificial faeces, upon
exposure to increasing doses of
405 nm light at an irradiance of
155.8 mW cm-2. Data points
show the mean counts
(n = 3) ± SD. Asterisks
indicate light-exposed samples
that were significantly different
to non-exposed final control
samples (P B 0.05), using one-
way ANOVA. No significant
decrease was observed in the
final control populations
(P C 0.05)
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when FCVwas suspended in DMEMwithout the FBS serum
additive; however, no significant difference was seen
between the inactivation kinetics. As the inactivation dose of
421 J cm-2 is 85% less than that required for a similar level
of inactivation in MM, it is likely that components of the
ORM are influencing FCV inactivation. A study investi-
gating the susceptibility of bacteriophage/C31 (Tomb et al.
2014) demonstrated similar results to those of the current
study: little inactivation was observed when exposed in a
simple salt solution; however, susceptibility was signifi-
cantly enhanced when suspended in a nutrient-rich medium,
with a 5.4 Log10 reduction of /C31 achieved after exposure
to 510 J cm-2. This was hypothesised to be due to the
complex protein and amino acid-rich composition of the
nutrient-rich medium, suggesting that some components
could be photosensitive and when exposed to 405 nm light
in the presence of oxygen, would produce ROS, damaging
the bacteriophage (Tomb et al. 2014). This same phe-
nomenon is likely to account for the enhanced inactivation
of FCV when suspended in DMEM and 10% FBS-DMEM,
as these contain a complex mixture of amino acids, vitamins
and sugar, which have the potential to absorb 405 nm light
(Fig. 5) and act as photosensitisers.
The photosensitisation of components of DMEM has
also been demonstrated upon exposure to light, with ribo-
flavin being shown to produce ROS which is further
enhanced by tryptophan, tyrosine, pyridoxine and folic acid
(Grzelak et al. 2001). Furthermore, blue-light wavelengths
are thought to be the most efficient for the photo-decom-
position of riboflavin and generation of ROS (Cheng et al.
2015). To investigate this, riboflavin was added to MM
with and without tyrosine, tryptophan, pyridoxine and folic
acid in the same concentrations found in DMEM (Table 1).
Results support this, with only 1.3 Log10 reduction when
only riboflavin was present; however, when all vitamins
and amino acids (riboflavin, tyrosine, tryptophan, pyri-
doxine and folic acid) were present, enhanced inactivation
of FCV was achieved with complete inactivation of a 105
PFU mL-1 population.
It is important to consider how light-induced inactivation
would be influenced when viral particles were suspended in
more biologically-relevant, naturally occurring matrices
such as body fluids or secretions. As artificial saliva and
artificial faeces can be prepared, these were used alongside
human blood plasma, as model human secretions in which
many viruses can be transmitted (Aitken and Jeffries 2001).
Results (Fig. 4) demonstrated that, similar to inactivation
in ORM (DMEM and 10% FBS-DMEM), viral suscepti-
bility was significantly increased when suspended in these
biologically-relevant fluids. Of the three model fluids used,
sensitivity was the highest when suspended in artificial
saliva, with a 5.1 Log10 reduction of FCV infectivity being
achieved after a dose of 421 J cm-2—the same as that
observed when suspended in ORM. Susceptibility was
slightly reduced when suspended in blood plasma
(4.8 Log10 inactivation with 561 J cm
-2), and further
reduced when suspended in artificial faeces, with more than
three times the dose required to achieve a 4.5 Log10 reduc-
tion. The reduced levels of 405 nm light transmission
through the blood plasma and artificial faeces will contribute
Fig. 5 Fluorescence spectra of
minimal medium [Dulbecco’s
phosphate buffered saline
(DPBS)] and organically-rich
media [Dulbecco’s modified
eagle’s medium (DMEM), 10%
foetal bovine serum-
supplemented DMEM (10%
FBS-DMEM), artificial saliva,
artificial faeces and blood
plasma] using an excitation
wavelength of 405 nm
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to these slower inactivation rates, with average values of
2.12 and 0.05% transmission levels of 405 nm recorded for
blood plasma and artificial faeces, respectively, compared to
30–40% transmission levels in all other ORM used. Overall,
the susceptibility values of FCV to 405 nm light when sus-
pended in artificial faeces, artificial saliva, blood plasma and
other organically rich media were significantly increased
compared to the susceptibility in minimal media, with
50–85% less dose being required for similar levels of viral
inactivation. Inactivation when suspended in these ORM is
likely due to the proteins contained within the media, for
example, the mucin in the artificial saliva, proteins within
the plasma, and inactivated yeast within the artificial faeces,
which may all be predisposed to photosensitisation
(demonstrated by the fluorescence peaks around 460 and
510–520 nm in Fig. 5). These results indicate the potential
for NoV susceptibility to 405 nm light to be enhanced when
suspended in ORM, or host secretions in which they are
released, such as faeces, blood and vomit. Although the
consistency and transparency/opacity may differ to those
used in this study, these fluids are likely to be rich in
molecules which could potentially be sensitive to 405 nm
light, thereby aiding in the NoV inactivation.
The results of this study provide first proof-of-concept
demonstrating that the antimicrobial efficacy of 405 nm
light can be extended to medically important viruses, with
the susceptibility being significantly enhanced when the
viral particles are contained within biologically-relevant
media. Further work should be carried out to establish the
effects of 405 nm light on other NoV surrogates, such as
Murine Norovirus and Tulane Virus, which may be more
resistant to decontamination. This will ensure that the
antiviral efficacy of 405 nm light is not over/under-esti-
mated and allows for a more accurate quantification of the
dose required for NoV inactivation. In addition, as this
work used a small-scale LED source with a high irradiance
output to establish the inactivation kinetics, and further
investigations are therefore required to investigate the
effectiveness of 405 nm light against airborne and surface-
deposited viruses, using low irradiance light applied con-
tinuously over long periods, similar to that employed in
clinical decontamination evaluations (Maclean et al.
2010, 2013a; Bache et al. 2012). Further studies could lead
to the beneficial application of 405 nm light for the
decontamination of air, surfaces and equipment in health-
care settings, as well as in other indoor locations, where
transmission of viral pathogens is a significant occurrence.
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